Avalere Health promoted COO Amar Urhekar to the CEO post on Thursday morning.

Shawn Murphy, VP, Thought Leadership Innovation Foundation (TLI)Limb loss and limb difference impact millions of people globally, with over 2.3 million individuals in the United States alone who are affected, a number expected to rise to 3.6 million by 2050. This rise in prevalence presents significant healthcare and economic challenges, necessitating innovative, data-driven solutions to improve patient care, quality of life (QOL) and healthcare equity. The National Institutes of Health (NIH) has taken a leading role in addressing these challenges by supporting the creation of a national registry to capture comprehensive data on limb loss and limb difference. This registry collects crucial patient information that helps inform both clinical care and research. Building on this, the not-for-profit community is now advancing these efforts forward, ensuring that data collection becomes a cornerstone of future advancements in this field of healthcare.Historically, limb loss and limb difference care have been constrained by fragmented and siloed data and outdated research. However, advances in data analytics are contemporizing the field by offering insights into patient outcomes and informing more effective healthcare policies. A registry allows for the consolidation of this data into valuable information, providing a holistic view of patient demographics, clinical outcomes and the effectiveness of treatments over time. Limb loss and limb difference place a substantial financial burden on individuals and healthcare systems, with lifetime healthcare costs averaging $509,275 for someone with limb loss, compared to $361,200 for those without

With over two decades of healthcare marketing experience, Muredda joins Ogilvy from Avalere Health, where he served as President of Marketing.